Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
489
Employees489
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
489
Employees489

ARDX Key Statistics

Market cap
1.47B
Market cap1.47B
Price-Earnings ratio
-23.25
Price-Earnings ratio-23.25
Dividend yield
Dividend yield
Average volume
3.04M
Average volume3.04M
High today
$6.12
High today$6.12
Low today
$5.91
Low today$5.91
Open price
$6.07
Open price$6.07
Volume
2.25M
Volume2.25M
52 Week high
$8.40
52 Week high$8.40
52 Week low
$3.21
52 Week low$3.21

Stock Snapshot

With a market cap of 1.47B, Ardelyx(ARDX) trades at $6.00. The stock has a price-to-earnings ratio of -23.25.

During the trading session on 2026-03-12, Ardelyx(ARDX) shares reached a daily high of $6.12 and a low of $5.91. At a current price of $6.00, the stock is +1.5% higher than the low and still -1.9% under the high.

Trading activity shows a volume of 2.25M, compared to an average daily volume of 3.04M.

Over the past 52 weeks, Ardelyx(ARDX) stock has traded between a high of $8.40 and a low of $3.21.

Over the past 52 weeks, Ardelyx(ARDX) stock has traded between a high of $8.40 and a low of $3.21.

ARDX News

Simply Wall St 2d
Ardelyx Valuation Check After Recent Share Price Weakness And Growth Expectations

Without a clear single event driving headlines today, Ardelyx (ARDX) still attracts attention as investors weigh recent share performance against its current ma...

Ardelyx Valuation Check After Recent Share Price Weakness And Growth Expectations
Simply Wall St 6d
Is Ardelyx’s 2026 IBSRELA Outlook Altering The Investment Case For Ardelyx?

Ardelyx, Inc. has reported past full-year 2025 results, with revenue of US$407.32 million versus US$333.62 million a year earlier, while net loss widened to US$...

Is Ardelyx’s 2026 IBSRELA Outlook Altering The Investment Case For Ardelyx?

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.